WHO ICTRP trial
Autologous cytokine-induced killer (CIK) cells in the treatment of hematological…
ChiCTR-TNRC-11001806 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-TNRC-11001806 |
|---|---|
| Public title | Autologous cytokine-induced killer (CIK) cells in the treatment of hematological malignancies |
| Scientific title | Autologous cytokine-induced killer (CIK) cells in the treatment of hematological malignancies |
| Primary sponsor | Southwest Hospital, Third Military Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | I+II (Phase I+Phase II) |
| Countries | China |
| Conditions | Hematological malignancies |
| Interventions | 1:Autologous CIK cells;2:Routine supportive care |
| Registration date | Dec 14, 2011 |
| Target size | 1:50;2:50 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: